Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis
NCT03267394 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2017-08-30
Summary
This study aims to assess the value of TARC in diagnosis of allergic Bronchopulmonary Aspergillosis.
Conditions
- Thymus and Activation Regulated Chemokine
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-31
- Primary Completion
- 2018-10-31
- Completion
- 2018-11-30
More Related Trials
-
Thymic Function in Patients With COVID-19
NCT04716907 ·Status: COMPLETED
-
Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
NCT07239544 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.
NCT02602249 ·Status: UNKNOWN ·Phase: PHASE1
-
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
NCT00173290 ·Status: UNKNOWN
-
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
NCT04836793 ·Status: UNKNOWN
-
Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer
NCT00272649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of NK Cells to Detect Blood Infection in ALL.
NCT06160115 ·Status: NOT_YET_RECRUITING
-
Identification of B Regulatory Cells by Flow Cytometry
NCT06876506 ·Status: NOT_YET_RECRUITING
-
Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19
NCT04379466 ·Status: COMPLETED
-
Investigation of Lymph Node Biology in Kidney Cancer
NCT07038733 ·Status: RECRUITING ·Phase: NA
-
Tumor-specific T Cells in Lung Cancer
NCT02515760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The COX-2 Gene and the Immune System
NCT01678222 ·Status: COMPLETED
-
Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors
NCT05238792 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies
NCT02880046 ·Status: UNKNOWN
-
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer
NCT02362451 ·Status: TERMINATED ·Phase: PHASE2
-
Thymosin Alpha-1 for irAE Secondary to ICIs
NCT06178146 ·Status: RECRUITING ·Phase: PHASE4
-
Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection
NCT04362865 ·Status: COMPLETED
-
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
NCT00863395 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
NCT00023985 ·Status: COMPLETED ·Phase: PHASE1
-
Regulatory T-cells After Subcutaneous Immunotherapy
NCT01830673 ·Status: COMPLETED
-
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
NCT05292859 ·Status: COMPLETED
-
Dendritic Cell Vaccination for Patients with Solid Tumors
NCT01291420 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
TIGIT in Patients With Chronic Myeloid Leukemia
NCT04818619 ·Status: UNKNOWN
-
Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
NCT07258160 ·Status: RECRUITING ·Phase: PHASE2
-
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
NCT04948619 ·Status: RECRUITING ·Phase: PHASE2